Arcadia BiosciencesNASDAQ: RKDA

Arcadia Biosciences (RKDA) witnesses a solid 42% improvement in Zola sales in Q2. The company continues to invest to grow the Zola brand through mass market retailers and grocery store chains.

Arcadia Biosciences (RKDA) came out with quarterly earnings of $0.78 per share, missing the Zacks Consensus Estimate of $1.27 per share. This compares to loss of $2.64 per share a year ago.

LOS ANGELES--(BUSINESS WIRE)--Prime Therapeutics Fails to Silence AHF in PBM Price-Fixing Arbitration.

DALLAS--(BUSINESS WIRE)--Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the second quarter and first half of 2024 after market close on August 13, 2024. The company has scheduled a conference call for 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss second-quarter results and key strategic achievements. Interested participants can joi.

Arcadia Biosciences (RKDA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Arcadia Biosciences (RKDA) is using the sale of its GoodWheat brand to expand its wheat intellectual property.

Arcadia Biosciences, Inc.® (Nasdaq: RKDA) will be hosting a call for analysts and investors on May 22, 2024, after the market closes. The conference call, scheduled for 4:30 p.m. Eastern time (1:30 p.m. Pacific time), will focus on recent strategic transactions. Interested participants can join the call through an audio-only webcast.

Arcadia Biosciences (RKDA) saw improved Q1 results due to a reduction in operating costs.

Arcadia Biosciences, Inc. and Above Food Corp. have announced that Above Food will acquire the GoodWheatTM brand from Arcadia for $4 million. This marks the start of a partnership between the two companies.